arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 1901.01286physics.med-phnucl-ex
收藏

利用逆运动学生产医用放射性同位素的新方法:治疗诊断用放射性核素67 Cu的成功生产试验

A novel approach to medical radioisotope production using inverse kinematics: a successful production test of the theranostic radionuclide 67Cu

G Souliotis, M Rodrigues, K Wang, V Iacob, N Nica, B Roeder, G Tabacaru, M Yu, P Zanotti-Fregonara, A Bonasera

摘要:

开发了一种生产重要医用放射性同位素的新方法。该方法基于在逆运动学中执行核反应,即在轻目标(例如H、d、He)上发送适当能量的重离子束并收集感兴趣的同位素。在这项工作中,作为一个概念的验证,我们研究了生产的治疗诊断放射性核素67 Cu(T1/2 =62小时)通过反应的70 Zn束在15 MeV/核子与氢气目标。67 Cu放射性核素以及其他伴生同位素在Al捕集器箔上的气体靶之后收集,并通过离线γ射线分析测量其放射性。辐照结束36 h后,除了目标产物67 Cu外,来自70 Zn +p反应的主要放射性杂质为69 mZn(T1/2 =13.8 h),其可通过进一步放射性冷却还原。此外,除了在逆运动学中产生的感兴趣的放射性核素之外,通过利用来自反应的前向聚焦中子并使它们与次级靶相互作用,可以产生额外的放射性同位素。在本研究中实现了对这一概念的初步成功测试。获得适合于临床前研究的活动的主要要求是开发高强度重离子原束。

英文摘要:

A novel method for the production of important medical radioisotopes has been developed. The approach is based on performing the nuclear reaction in inverse kinematics, namely sending a heavy-ion beam of appropriate energy on a light target (e.g. H, d, He) and collecting the isotope of interest. In this work, as a proof-of-concept, we studied the production of the theranostic radionuclide 67Cu (T 1/2 =62 h) via the reaction of a 70Zn beam at 15 MeV/nucleon with a hydrogen gas target. The 67Cu radionuclide, alongside other coproduced isotopes, was collected after the gas target on an Al catcher foil and their radioactivity was measured by off-line γ-ray analysis. After 36 h from the end of the irradiation, apart from the product of interest 67Cu, the main radioimpurity coming from the 70Zn+p reaction was 69mZn (T 1/2 =13.8 h) that can be reduced by further radio-cooling. Moreover, along with the radionuclide of interest produced in inverse kinematics, the production of additional radioisotopes is possible by making use of the forward-focused neutrons from the reaction and letting them interact with a secondary target. A preliminary successful test of this concept was realized in the present study. The main requirement to obtain activities appropriate for preclinical studies is the development of high-intensity heavy-ion primary beams.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑